Yixintang Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 17,431.62 million compared to CNY 14,587.4 million a year ago. Net income was CNY 1,009.39 million compared to CNY 921.58 million a year ago.

Basic earnings per share from continuing operations was CNY 1.7011 compared to CNY 1.5615 a year ago.